InvestorsHub Logo
Followers 24
Posts 1519
Boards Moderated 0
Alias Born 05/22/2010

Re: None

Thursday, 03/16/2017 8:28:28 AM

Thursday, March 16, 2017 8:28:28 AM

Post# of 5098
I will add my thoughts later about the "numbers" and Richards quiet moves with the share standings.. For now, hang in there and here is More news this morning just out now.. NEW news..

CHARLOTTE, North Carolina, March 16, 2017 /PRNewswire/ --

Encompass Compliance Corp. (OTC PINK:ENCC) announces a channel sales agreement with Madison Avenue Drug Testing.

Encompass Compliance Corp. is the most comprehensive provider of workplace drug and alcohol testing compliance services, with over 30 years of experience. We are dedicated to providing employers with the tools necessary to mitigate regulatory and compliance risk. Our solutions provide organizations with up-to-date policies, a comprehensive resource center and real-time monitoring for drug and alcohol testing orders.

Madison Avenue Drug Testing (http://madisonavenueproducts.com) is a premier provider of drug testing products to corporations throughout the U.S. They provide products that test for: THC, alcohol, cocaine, amphetamines, methamphetamines, opiates, benzodiazepines, propoxyphene, PCP, oxycodone, morphine, ecstasy, methadone, buprenorphine, barbiturates, ketamine, K2, tramadol, ETG. "As a supplier of drug testing products to over 3,000 companies, they are a natural fit to provide our Risk Shield Compliance services to their customers," says Encompass CEO, Richard Sharp .

Madison Avenue Drug Testing CEO Keith Devine says, "We feel extremely fortunate to be selected by Encompass Inc. as a channel partner. Combining the best legal minds in the business with our diverse clientele, instills confidence in our customers that they are provided the most comprehensive state specific compliance solutions available."

There will be joint marketing activities such as webinars, regular mailings and updates on a regular basis to Madison Avenue Drug Testing Customers.